OyaGen's Debt Round

OyaGen raised a round of funding on December 12, 2017.

OyaGen is a biotechnology company discovering, developing, and commercializing pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. The company will pursue several assays…

Articles about OyaGen's Debt Round: